Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Berg

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Anti-Cancer Drugs|October 1, 2004
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell linesLinna Zhang, Sharon E Plon, Jed G Nuchtern, et al.
Journal of the National Cancer Institute|January 31, 2016
An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood CancerYoram Unguru, Conrad V Fernandez, Brooke Bernhardt, et al.
Pediatric Blood & Cancer|September 13, 2011
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962)Samara L Poplack Potter, Stacey Berg, Ashish Mark Ingle, et al.
Journal of Biomolecular Screening|February 15, 2014
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer TherapyNenggang Zhang, Kathleen Scorsone, Gouqing Ge, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisSusan M Blaney, Richard Heideman, Stacey Berg, et al.
Pediatric Blood & Cancer|May 3, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)Eric S Schafer, Rachel E Rau, Stacey Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Intrathecal mafosfamide: a preclinical pharmacology and phase I trialSusan M Blaney, Frank M Balis, Stacey Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX ModelsMari Kogiso, Lin Qi, Frank K Braun, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Anti-Cancer Drugs|October 1, 2004
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell linesLinna Zhang, Sharon E Plon, Jed G Nuchtern, et al.
Journal of the National Cancer Institute|January 31, 2016
An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood CancerYoram Unguru, Conrad V Fernandez, Brooke Bernhardt, et al.
Pediatric Blood & Cancer|September 13, 2011
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962)Samara L Poplack Potter, Stacey Berg, Ashish Mark Ingle, et al.
Journal of Biomolecular Screening|February 15, 2014
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer TherapyNenggang Zhang, Kathleen Scorsone, Gouqing Ge, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisSusan M Blaney, Richard Heideman, Stacey Berg, et al.
Pediatric Blood & Cancer|May 3, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)Eric S Schafer, Rachel E Rau, Stacey Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Intrathecal mafosfamide: a preclinical pharmacology and phase I trialSusan M Blaney, Frank M Balis, Stacey Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX ModelsMari Kogiso, Lin Qi, Frank K Braun, et al.
Pageof 2